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Background 
Because more than 90 percent of circulating cortisol in 
human serum is protein-bound, changes in binding proteins 
can alter measured serum total cortisol concentrations 
without influencing free concentrations of this hormone. 
Hypotheses 
Patients with presumably normal adrenal function but 
decreased cortisol-binding proteins will have lower-than-
expected concentrations of serum total cortisol but 
appropriately elevated free cortisol levels. 
Measurement of serum free cortisol concentrations will 
identify patients with normal or even increased adrenal 
function, who, on the basis of low total cortisol 
concentrations, would otherwise have been incorrectly 
considered to have adrenal insufficiency. 
Methods 
Setting: Medical, surgical, and cardiac ICUs and general 
medical ward of a tertiary care U.S. academic medical 
center. 
Patients and Measurements: Baseline serum total cortisol, 
cosyntropin-stimulated
 serum total cortisol, aldosterone, and 
free cortisol concentrations
 were measured in 66 critically ill 
patients with an APACHE score of 15 or higher, 33 healthy 
volunteers, and 7 patients with adrenal insufficiency 
secondary to hypopituitarism. Patients were further divided 
into two groups based on their serum albumin 
concentrations of ≤ 2.5 g/dL (low albumin group, n=36) or 
>2.5 g/dL (normal albumin group, n=30). 
Results 
Baseline and cosyntropin-stimulated serum total cortisol
 
concentrations were significantly lower in the low albumin 
group than the normal albumin group. However, serum
 free 
cortisol concentrations were similar in the two groups and 
were several times higher than the values in healthy 
controls. Fourteen of thirty-six (39%) low albumin patients 
had subnormal cosyntropin stimulated total cortisol 
concentrations, consistent with a traditional diagnosis of 
adrenal insufficiency. These same patients had high-normal 
or elevated serum free cortisol concentrations. 
Conclusion 
Nearly 40 percent of critically ill patients with
 
hypoproteinemia had subnormal serum total cortisol 
concentrations,
 even though their adrenal function was 
normal. Measuring serum
 free cortisol concentrations in 
critically ill patients with
 hypoproteinemia may help prevent 
the unnecessary use of glucocorticoid
 therapy. 
 
Commentary 
The incidence of “adrenal insufficiency” in sepsis and septic 
shock is believed to be between 30 to 70%. Adrenal 
insufficiency is frequently characterized clinically as 
hypotension resistant to volume resuscitation and 
dependent on vasopressors. Two studies in the 1990’s 
showed that the use of stress doses of hydrocortisone 
decreased the duration of vasopressor therapy and 
improved shock reversal.
1,2 In 2002, a large multicenter, 
randomized, placebo controlled trial demonstrated that 
steroids improved mortality in patients with septic shock 
who had relative adrenal insufficiency, defined as an 
increase in total cortisol ≤ 9 µg/dL in response to a 250 µg 
cosyntropin stimulation test.
3 This has formed the basis for 
the current practice of treating patients with septic shock 
and adrenal insufficiency with stress doses of steroids. Critical Care   December 2004 Vol 9 No 1    Dubey and Boujoukos 
However, there is controversy about the best indicator of 
adrenal insufficiency in the critically ill patients. Several 
criteria have been suggested, including, total cortisol ≤ 
18µg/dL or change in total cortisol ≤ 9 µg/dL in response to 
cosyntropin stimulation test, and total random cortisol level 
≤ 25 µg/dL. 
Free cortisol is the physiologically active form of the 
hormone. In a healthy person, 10% of the cortisol is present 
in the free form, 20% is bound to albumin, and 70% is 
bound to cortisol binding globulin. Earlier studies have 
demonstrated that after a stressor like surgery, the 
concentration of cortisol binding globulin decreases by 50%, 
total cortisol levels increase by 55-100%.
4,5 However, 
surrogate markers of free cortisol, such as the free cortisol 
index (FCI), and calculated free cortisol levels increase by 
130 to 600%. Importantly, these methods of free cortisol 
determination do not take into account the changes in 
serum albumin levels that occur in critical illness. 
The current study by Hamrahian et al. demonstrates 
significant variability in serum total cortisol levels in the 
presence of hypoproteinemia. It shows that up to 39% of 
patients with low albumin levels would be misdiagnosed as 
being adrenally insufficient based on total cortisol levels. 
Levels in these patients appear to be low due to 
hypoproteinemia. Their free cortisol levels seem to be 
preserved and may in fact be elevated.  
There are several important limitations of this study that 
deserve consideration. This study included 18 patients with 
sepsis but none with septic shock or multi-organ 
dysfunction; i.e., the patients most likely to benefit from 
corticosteroid administration were excluded. Because of this 
omission, it is difficult to know how to apply the present 
findings to this clinically important group. Furthermore, the 
physiological status of study patients at the time of cortisol 
measurements was not well defined, which makes it difficult 
to determine how free cortisol levels equate with other 
clinical parameters. Additionally, the technique for 
measuring free cortisol is difficult and expensive and not 
widely available.  Finally, no standard levels of free cortisol 
have been reported, so the definition of abnormal for this 
parameter remains uncertain. 
Like many studies, this one raises a number of interesting 
questions. First, what is the true incidence of adrenal 
insufficiency in the critically ill? Second, if we are not 
measuring and treating true adrenal insufficiency in septic 
hypoproteinemic patients, then what are we treating? Third, 
how does one reconcile the mortality benefit seen in the 
study by Annane and colleagues,
3 which used change in 
total cortisol to discriminate responders from non-
responders? Finally, does free cortisol really matter? 
CORTICUS, an ongoing 800-patient multicenter trial, should 
help
 to answer these important questions. CORTICUS will 
test the hypothesis that low dose steroids improves 28-day 
mortality in patients with septic shock whose cortisol levels 
do not increase by more than 9 µg/dL in response to 
corticotropin stimulation.
6 In addition, the investigators will 
compare total and free cortisol levels in these patients. 
Recommendation 
Until CORTICUS is completed, we recommend that a) all 
patients in septic shock with ≤ 9 µg/dL total cortisol 
response to corticotropin stimulation receive low-dose 
corticosteroids, and b) free cortisol levels should not be 
used to determine adrenal responsiveness. 
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